Experiment 1175349
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | MAROUN,JA: MAKSYMIUK,A: EISENHAUER,E: STEWART,DJ: YOUNG,V: PATER,J:. (1986). PHASE II STUDY OF ACIVICIN IN NON-SMALL CELL LUNG CANCER: A NATIONAL CANCER INSTITUTE OF CANADA STUDY.. 70(11) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN THIS PHASE II STUDY, 36 PATIENTS WITH PREVIOUSLY UNTREATED NON-SMALL CELL LUNG CANCER WERE TREATED. STARTING DOSE WAS 15 MG/SQ.M. FOR 5 DAYS REPEATED EVERY 21 DAYS. OF 33 EVALUABLE PATIENTS THERE WERE 2 PARTIAL REMISSIONS AND 7 MINOR RESPONSES. HEMATOLOGICAL TOXICITY WAS DOSE RELATED WITH ONE DEATH DUE TO NEUTROPENIC SEPSIS AT 18 MG/SQ.M. GASTROINTESTINAL TOXICITY WAS THE MOST PREVILANT NON-HEMATOLOGICAL TOXICITY. NEUROLOGICAL SYMPTOMS WERE SEEN IN 48% OF THE PATIENTS. |
| Dose amount | 15-18 MG |
| Number | 1 |
| Qualitative result | EQUIVOCAL |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |